• AM251 in Mechanistic Neuroimmunology: Beyond CB1 Antagonism

  2026-05-14

  Explore the multifaceted role of AM251 as a CB1 receptor antagonist in neuroimmunology and metabolic research. This article delivers new insights linking endocannabinoid signaling to neural and immune functions, uniquely positioning AM251 for advanced cannabinoid receptor research.

• BODIPY 581/591 C11: Ratiometric Probe for Lipid Peroxidation

  2026-05-14

  BODIPY 581/591 C11 stands out as a ratiometric fluorescent probe, enabling robust lipid peroxidation detection and antioxidant evaluation in live cells. Its unique red-to-green emission shift streamlines quantitative oxidative stress measurement and troubleshooting, making it indispensable for ferroptosis and bone metabolism research.

• Forskolin as an Adenylate Cyclase Activator: Protocols & Inn

  2026-05-13

  Forskolin is a gold-standard adenylate cyclase activator that empowers cell signaling, stem cell differentiation, and disease modeling with proven reproducibility. This article delivers actionable workflows, troubleshooting guides, and direct insights from pivotal studies, making it essential reading for researchers seeking reliable results with Forskolin.

• 5-Ethynyl-2'-deoxyuridine (5-EdU) for Precision Cell Prolife

  2026-05-13

  5-Ethynyl-2'-deoxyuridine (5-EdU) revolutionizes cell proliferation assays by enabling rapid, morphology-preserving S phase detection through click chemistry. Its robust workflow supports high-throughput tissue regeneration and tumor growth research, outperforming traditional BrdU assays in both sensitivity and operational simplicity.

• Tamsulosin Reduces Postoperative Urinary Retention: Meta-Ana

  2026-05-12

  This systematic review and meta-analysis is the first to focus exclusively on Tamsulosin for the prevention of postoperative urinary retention (POUR) across a broad surgical population. The findings demonstrate that Tamsulosin significantly lowers the risk of POUR and increases urinary flow rates, informing both clinical practice and translational research in smooth muscle and urological disease models.

• Benzyl Quinolone Carboxylic Acid: Precision in M1 Receptor M

  2026-05-12

  Benzyl Quinolone Carboxylic Acid (BQCA) empowers researchers to dissect M1 muscarinic acetylcholine receptor signaling with unmatched selectivity. This guide details optimized workflows, practical troubleshooting, and cutting-edge insights for cognitive and Alzheimer's disease research—leveraging the latest mechanistic discoveries.

• Omeprazole (A2845): Lab Use Guidance for H+,K+-ATPase Inhibi

  2026-05-11

  Omeprazole (A2845) addresses experimental needs in gastric acid secretion research and antiulcer activity studies by providing a high-purity H+,K+-ATPase inhibitor with validated protocol and QC recommendations. It is intended strictly for controlled scientific workflows and must not be used in diagnostic or therapeutic applications.

• Tobramycin: In-Depth Mechanistic Insights for Precision Assa

  2026-05-11

  Explore Tobramycin as a leading aminoglycoside antibiotic for advanced microbiology research. This article offers a unique, mechanistic perspective and practical assay guidance, grounded in recent comparative studies.

• HDAC Inhibitors as NUT Function Repressors in NUT Carcinoma

  2026-05-10

  This study introduces a high-throughput chemical screening strategy that identifies diverse histone deacetylase (HDAC) inhibitors as potent repressors of NUT function in NUT carcinoma (NC). The findings provide mechanistic insight into epigenetic regulation in NC and suggest HDAC inhibition as a promising therapeutic avenue for this aggressive malignancy.

• BQCA and Biased M1 Signaling: Strategic Insights for Transla

  2026-05-09

  This article provides an in-depth, evidence-backed exploration of Benzyl Quinolone Carboxylic Acid (BQCA) as a selective M1 muscarinic receptor potentiator, connecting mechanistic advances in GRK-mediated signaling bias to actionable strategies for translational cognitive and Alzheimer’s disease research. By contextualizing new findings with protocol guidance and comparative analysis, it empowers researchers to optimize workflows beyond conventional product pages.

• Ibuprofen as an Emerging Contaminant: Toxicology and Biodegr

  2026-05-08

  Jan-Roblero and Cruz-Maya’s 2023 review highlights the environmental persistence and toxicological risks of ibuprofen, a widely used nonsteroidal anti-inflammatory drug (NSAID). The paper synthesizes evidence on the drug’s mechanisms of toxicity, challenges in environmental degradation, and the potential for bacterial biodegradation, with implications for advancing sustainable anti-inflammatory research.

• Fasudil (HA-1077) HCl: Optimized ROCK Inhibition for Cell As

  2026-05-08

  Fasudil (HA-1077) HCl from APExBIO delivers precise, reproducible inhibition of the Rho/ROCK pathway, underpinning advanced studies in cell migration, proliferation, and apoptosis. Its robust solubility and validated efficacy make it a preferred choice for cancer and disease modeling, with uniquely actionable insights for troubleshooting and protocol design.

• Nimbolide-Induced PARP1 Trapping via RNF114 in BRCA-Mutated

  2026-05-07

  Li et al. identify RNF114 as a PARylation-dependent E3 ligase that regulates PARP1 removal from DNA lesions. Nimbolide, by inhibiting RNF114, induces PARP1 trapping and synthetic lethality in BRCA-mutated cancers, offering a new therapeutic axis and overcoming PARP inhibitor resistance.

• Indometacin Sodium: Precision Tools for Advanced Inflammatio

  2026-05-07

  Indometacin Sodium Trihydrate empowers researchers with reproducible, high-impact results in inflammation and neuroregeneration studies. Its multi-modal inhibition and workflow flexibility set a new benchmark for COX inhibitor applications, from prostaglandin assays to myelin repair protocols.

• Tacrine Hydrochloride Hydrate: Precision Tools for Alzheimer

  2026-05-06

  Tacrine hydrochloride hydrate (Tetrahydroaminacrine) empowers Alzheimer’s disease research with unmatched specificity and reproducibility, serving as a gold-standard acetylcholinesterase inhibitor. Explore robust protocols, advanced applications, and expert troubleshooting strategies that maximize the translational value of APExBIO’s high-purity formulation.

8243 records 21/550 page Previous Next First page 上5页 2122232425 下5页 Last page